Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 12/20 | 0.82 |
| ▸ | CA1 | P00915 | 12/20 | 0.82 |
| ▸ | CA2 | P00918 | 12/20 | 0.82 |
| ▸ | CA9 | Q16790 | 12/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11135995 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL11436646 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL672928 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| Potassium Ion SCHEMBL229878 | 0.95 | — | — | |
| SCHEMBL2579283 | 0.95 | — | — | |
| SCHEMBL673637 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL672341 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL8506272 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL11458459 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL31612418 | 0.95 | CA12 (0.82) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3969490-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS | BRIDGESTONE CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12565546-B2 | Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer | LG CHEM, LTD. (KR) | 2026-03-03 | — | — | US | disclosed |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12410263-B2 | Modified high-Cis polybutadiene polymer, related methods and rubber compositions | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| EP-4032921-B1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | LG CHEMICAL LTD (KR) | 2025-08-27 | — | — | EP | disclosed |
| US-12371516-B2 | Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-12264232-B2 | Modified high-cis polybutadiene polymer, related methods and tire components | BRIDGESTONE CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| US-20250066516-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| US-12209149-B2 | Continuous preparation system of conjugated diene-based polymer | LG CHEM, LTD. (KR) | 2025-01-28 | — | — | US | disclosed |
| CN-113825777-B | Modified high cis polybutadiene polymers, related methods and tire components | 株式会社普利司通 | 2025-01-28 | — | — | CN | disclosed |
| US-7008899-B2 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2006-03-07 | — | — | US | disclosed |
| WO-2005061563-A1 | BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2005-07-07 | — | — | WO | disclosed |
| US-20050131174-A1 | Bulk polymerization process for producing polydienes | BRIDGESTONE CORP. | 2005-06-16 | — | — | US | disclosed |
| US-6897270-B2 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20050038215-A1 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2005-02-17 | — | — | US | disclosed |
| US-20040116638-A1 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| US-6699813-B2 | COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS | BRIDGESTONE CORPORATION (JP) | 2004-03-02 | — | — | US | disclosed |
| EP-1370593-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | Bridgestone Corporation (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-20030176276-A1 | Lanthanide-based catalyst composition for the manufacture of polydienes | BRIDGESTONE CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
| WO-2002068484-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | BRIDGESTONE CORPORATION (JP) | 2002-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565546-B2 | Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer | CARM1, RIF1, UFM1 | CA12 4569/4885CA1 4752/4885CA2 4861/4885 |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | MALT1, INO80C, RTCB | CA12 997/4885CA1 678/4885CA2 2025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.